Chronic dialysis‐associated anaemia in end‐stage renal disease: analysis of management in two French centres

Background:  Treatment of anaemia in renal‐insufficient patients relies on the use of an erythropoiesis‐stimulating agent (ESA). This study aimed to compare the impact of two different strategies of ESA prescribing on variation in haemoglobin (Hb) concentration in end‐stage renal disease (ESRD) patients.

[1]  P. Bárány,et al.  Maintaining control over haemoglobin levels: optimizing the management of anaemia in chronic kidney disease. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[2]  M. Waterschoot.  Evaluation of response to various erythropoiesis--stimulating proteins using anemia management software. , 2007, Journal of renal care.

[3]  Alan Perkins,et al.  Results of the European Survey on Anaemia Management 2003 (ESAM 2003): current status of anaemia management in dialysis patients, factors affecting epoetin dosage and changes in anaemia management over the last 5 years. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[4]  F. Locatelli,et al.  Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[5]  F. Locatelli,et al.  Dialysis adequacy and response to erythropoietic agents: what is the evidence base? , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[6]  J. Lazarus,et al.  Effect of variability in anemia management on hemoglobin outcomes in ESRD. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[7]  P. Stenvinkel.  The role of inflammation in the anaemia of end-stage renal disease. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[8]  F. Locatelli,et al.  Novel erythropoiesis stimulating protein for treatment of anemia in chronic renal insufficiency. , 2001, Kidney international.

[9]  G. Cancarini,et al.  Adequacy of dialysis reduces the doses of recombinant erythropoietin independently from the use of biocompatible membranes in haemodialysis patients. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[10]  NKF-DOQI clinical practice guidelines for hemodialysis adequacy. National Kidney Foundation. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[11]  J. Daugirdas.  Second generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error. , 1993, Journal of the American Society of Nephrology : JASN.